However, due to its incretin function, GLP-1 is also known to normalize plasma glucose, especially in patients suffering from obesity and diabetes which might act as a counter mechanism for the increased hyperglycemia-induced impaired gastric motility observed after PD [36,37]. The gene discussed is GCG; the disease is obesity disorder.